Cathy Burgess, Benjamin Wolf, Jong Ho "Philip" Won, Ph.D. The Food and Drug Administration’s (FDA) recent rejection of all study data from Mid-Link Testing highlights the importance of using reliable, ...

In the age of advanced data analytics and artificial intelligence (AI), organizations are continuously confronted with new and increasingly complex challenges of data legitimacy. The proliferation of ...

Global transaction flows from embedded payments could surpass $2.5 trillion by 2028, according to Juniper Research. This has implications for embedded treasury, a subset that deals specifically with ...

The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and potentially unreliable paper-based ...

Built-in data integrity is a bare minimum requirement in today’s BioPharmaceutical manufacturing. Good Manufacturing Practices (GMP) regulations of the Food and Drug Administration (FDA) highlight the ...

Artificial intelligence is no longer an emerging technology—it is an embedded reality shaping the way we live, govern and do business. From predictive healthcare to autonomous defense systems, AI is ...

Since linked documents can be modified after being linked to a communication, preserving the state of the document as it was at the time of the original communication can range from difficult to ...